These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 6143849

  • 1. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA, Metelitsa VI, Nazarenko VA, Martsevich SIu, Kulikova TV.
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [Abstract] [Full Text] [Related]

  • 2. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG, Nelson RR, Nordstrom LA, Diefenthal HC, Gobel FL.
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract] [Full Text] [Related]

  • 3. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA, Crawford MH, O'Rourke RA.
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [Abstract] [Full Text] [Related]

  • 4. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR, Mir MA.
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [Abstract] [Full Text] [Related]

  • 5. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu, Sagirov AM, Desiatnichenko VM, Sobol' IuS, Sumarokov AB.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983 Nov; 6(2):57-63. PubMed ID: 6139118
    [Abstract] [Full Text] [Related]

  • 6. [Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
    Ol'binskaia LI, Vartanova OA.
    Kardiologiia; 1986 Feb; 26(2):48-51. PubMed ID: 2422430
    [Abstract] [Full Text] [Related]

  • 7. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS, Fand RS.
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract] [Full Text] [Related]

  • 8. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB, Lacy CR, Krieger SD, Cosgrove NM.
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [Abstract] [Full Text] [Related]

  • 9. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr 18; 22(8):33-4. PubMed ID: 6102734
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B, Dahlqvist A, Raak A, Wrege U.
    Curr Med Res Opin; 1978 Apr 18; 5(5):388-93. PubMed ID: 26520
    [Abstract] [Full Text] [Related]

  • 11. [Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
    Ol'binskaia LI, Bragina GI.
    Kardiologiia; 1984 Apr 18; 24(4):9-13. PubMed ID: 6727119
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U, Blasini R.
    Herz; 1986 Feb 18; 11(1):55-61. PubMed ID: 2870014
    [Abstract] [Full Text] [Related]

  • 13. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W, Park J, DiBianco R, Singh SN, Katz RJ, Fletcher R.
    Chest; 1981 Oct 18; 80(4):425-30. PubMed ID: 6791883
    [Abstract] [Full Text] [Related]

  • 14. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM, Freedman SB, Thomson A, Carter G, Harris PJ, Kelly DT.
    J Cardiovasc Pharmacol; 1987 Oct 18; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [Abstract] [Full Text] [Related]

  • 15. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P, Prahl M.
    Ugeskr Laeger; 1973 May 17; 135(20):965-8. PubMed ID: 4148295
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A, Pagliarani PL, Guelfi P, Mattace R, Costa G, Bernardi G, Zacà F.
    Boll Soc Ital Cardiol; 1979 May 17; 24(7):741-5. PubMed ID: 45306
    [No Abstract] [Full Text] [Related]

  • 17. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W, Fluch N, Brandt D.
    Wien Klin Wochenschr; 1982 May 14; 94(10):258-61. PubMed ID: 6126961
    [Abstract] [Full Text] [Related]

  • 18. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL, Vukovich RA, Dennick LG, Groel JT, Willard DA.
    Clin Pharmacol Ther; 1980 Jan 14; 27(1):57-63. PubMed ID: 6101312
    [Abstract] [Full Text] [Related]

  • 19. Angina pectoris: effective therapy once daily.
    Prager G.
    J Int Med Res; 1979 Jan 14; 7(1):39-44. PubMed ID: 33863
    [Abstract] [Full Text] [Related]

  • 20. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A, Gregorini L, Valentini R.
    Cardiology; 1973 Jan 14; 58(6):369-75. PubMed ID: 4153721
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.